Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
4,404,649
-
Total 13F shares
-
3,067,678
-
Share change
-
-13,334
-
Total reported value
-
$3,536,532
-
Price per share
-
$1.15
-
Number of holders
-
13
-
Value change
-
-$23,289
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q4 2022
As of 31 Dec 2022,
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,067,678 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Rock Springs Capital Management LP, FMR LLC, VANGUARD GROUP INC, FIL Ltd, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, FRANKLIN RESOURCES INC, and Tower Research Capital LLC (TRC).
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.